Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

HDH Treatment Planning System

K-Number: K212173 · 2022-01-25

ApplicantCdb Corporation
Decision Date2022-01-25
Product CodePNN
Advisory CommitteeDE
DecisionSubstantially Equivalent

Device Summary

HDH Treatment Planning System is a medical device manufactured by Cdb Corporation. It received FDA 510(k) clearance on 2022-01-25 under approval number K212173. The device is classified under product code PNN. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the HDH Treatment Planning System?

HDH Treatment Planning System is a medical device that received FDA 510(k) clearance on 2022-01-25. It is manufactured by Cdb Corporation. The 510(k) number is K212173.

When was HDH Treatment Planning System approved by the FDA?

HDH Treatment Planning System received FDA 510(k) clearance on 2022-01-25, under approval number K212173.

What company makes HDH Treatment Planning System?

HDH Treatment Planning System is manufactured by Cdb Corporation.

What is the FDA product code for HDH Treatment Planning System?

The FDA product code for HDH Treatment Planning System is PNN.

Related Clinical Trials

NCT07614997 Effectiveness and Safety of the Ulthera® System for Skin Laxity in the Lower Face, Submentum and Neck NOT_YET_RECRUITING NCT05003843 BOLT: Study of the Indigo® Aspiration System When Used in Patients With Deep Vein Thrombosis ACTIVE_NOT_RECRUITING NCT07499128 Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event ENROLLING_BY_INVITATION NCT03280862 DANISH-CRT - Does Electric Targeted LV Lead Positioning Improve Outcome in Patients With Heart Failure and Prolonged QRS COMPLETED NCT05701917 DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis RECRUITING NCT07222787 Post-market Safety and Effectiveness of the CORUS-LX System in Improving Lumbar Interbody Fusion Outcomes RECRUITING

Related PubMed Literature

PMID: 41887630 Capacity building for ethical use of artificial intelligence in health: protocol for a scoping review of training initiatives and gaps in Africa. BMJ open (2026) PMID: 41533265 Modernizing Medical Software Regulation in Bangladesh: A Roadmap for Risk-Based SaMD Oversight. Journal of medical systems (2026) PMID: 41271017 Lymphedema Imaging and AI: A Review of Diagnostic Modalities, Biomarkers, and Clinical Integration. Biomedical journal (2025) PMID: 41251011 Effectivity of the Dehydrated Human Amnion/Chorion Membrane Allograft for Diabetic Foot Ulcers in Japan: A Case Series. International wound journal (2025)

Other Devices by Cdb Corporation

K160957CDB Self Ligating Bracket 8F K191823Clear-Aligners K210613HIT Clear Aligner

Related Devices (Code: PNN)

K1520863Shape Ortho System3Shape A/S K163677Ortho System3Shape A/S K162850GuideMia Ortho+Guidemia Technologies, LLC K181112Orchestrate 3DOrchestrate 3D K180941Ortho System3Shape A/S K171634Ortho System3Shape A/S

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑